1. Home
  2. BWAY vs MIN Comparison

BWAY vs MIN Comparison

Compare BWAY & MIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • MIN
  • Stock Information
  • Founded
  • BWAY 2003
  • MIN 1988
  • Country
  • BWAY Israel
  • MIN United States
  • Employees
  • BWAY N/A
  • MIN N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • MIN Trusts Except Educational Religious and Charitable
  • Sector
  • BWAY Health Care
  • MIN Finance
  • Exchange
  • BWAY Nasdaq
  • MIN Nasdaq
  • Market Cap
  • BWAY 280.7M
  • MIN 302.7M
  • IPO Year
  • BWAY 2019
  • MIN N/A
  • Fundamental
  • Price
  • BWAY $15.20
  • MIN $2.66
  • Analyst Decision
  • BWAY Strong Buy
  • MIN
  • Analyst Count
  • BWAY 2
  • MIN 0
  • Target Price
  • BWAY $18.00
  • MIN N/A
  • AVG Volume (30 Days)
  • BWAY 70.6K
  • MIN 331.0K
  • Earning Date
  • BWAY 08-13-2025
  • MIN 01-01-0001
  • Dividend Yield
  • BWAY N/A
  • MIN 7.31%
  • EPS Growth
  • BWAY 515.14
  • MIN N/A
  • EPS
  • BWAY 0.11
  • MIN 0.08
  • Revenue
  • BWAY $46,084,000.00
  • MIN N/A
  • Revenue This Year
  • BWAY $341.83
  • MIN N/A
  • Revenue Next Year
  • BWAY $23.42
  • MIN N/A
  • P/E Ratio
  • BWAY $52.60
  • MIN $33.38
  • Revenue Growth
  • BWAY 26.50
  • MIN N/A
  • 52 Week Low
  • BWAY $7.06
  • MIN $2.52
  • 52 Week High
  • BWAY $15.61
  • MIN $2.88
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 78.88
  • MIN 45.92
  • Support Level
  • BWAY $14.33
  • MIN $2.65
  • Resistance Level
  • BWAY $15.00
  • MIN $2.71
  • Average True Range (ATR)
  • BWAY 0.56
  • MIN 0.03
  • MACD
  • BWAY 0.33
  • MIN -0.00
  • Stochastic Oscillator
  • BWAY 90.26
  • MIN 14.29

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About MIN MFS Intermediate Income Trust

MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises of different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.

Share on Social Networks: